Z-1249-2019 Class II Terminated

Recalled by Roche Diagnostics Corporation — Indianapolis, IN

FDA device recall Z-1249-2019 was initiated by Roche Diagnostics Corporation on Mar 15, 2019 and is designated Class II. Reason for recall: The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and… The recall status is terminated (terminated Apr 23, 2020). Affected quantity: 149.

Recall details

Product Type
Devices
Report Date
May 8, 2019
Initiation Date
Mar 15, 2019
Termination Date
Apr 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
149

Product description

cobas e 801 immunoassay analyzer

Reason for recall

The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.

Distribution pattern

Distributed to accounts in AL AZ CA CT FL HI IA IL IN KY LA MA MD ME MI MN MO NC NH NJ NY OH OR PA PR SC TN TX VA WA WI

Code information

All units may experience this issue.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1249-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1249-2019. Report a data issue: hello@regdatalab.com.